Latest Financial Results News

Shine Justice Ltd has reported a strong turnaround in its half-year results to December 2025, posting an 8% revenue increase and a return to profitability with a $6.7 million net profit. The legal services firm saw robust growth in personal injury litigation and ongoing class actions, despite cash flow challenges from delayed settlements.

Anteris Technologies Global Corp. posted a $94.2 million loss for 2025 amid a 29% revenue decline, while progressing its pivotal DurAVR THV clinical trial and securing $320 million in early 2026 financings.

Catalyst Metals Limited delivered a robust half-year result with revenues up 50% and profits rising 40%, driven by higher gold prices and operational advances including a doubling of reserves in the Plutonic Gold Belt.

Beam Communications has turned around its fortunes, posting a $2 million net profit for the first half of FY26 and announcing a $12.1 million capital return following the divestment of Zoleo Inc.

Harvey Norman Holdings Limited reported a robust 6.9% rise in system sales revenue for 1H26, underpinned by strong Australian franchisee performance and overseas expansion. Profit before tax climbed 16.5%, boosted by property revaluations and disciplined cost management.

Jupiter Mines Limited reported a 15.7% rise in profit after tax for HY2026, driven by its stake in the Tshipi manganese mine and a key joint venture deal with Exxaro Resources. The company navigates production challenges and market shifts while preparing for a dividend decision.

Titomic Limited reports a significant drop in revenue and increased losses for the six months ending December 2025, alongside a strategic financial year change to align with global subsidiaries.

Mach7 Technologies reported a 23% drop in revenue to $13.65 million for H1 FY26, alongside a sharp increase in net loss to $5.75 million, as it embarks on a strategic commercial reset and expands its Asia-based engineering capabilities.

4DMedical Limited’s half-year report reveals rapid commercial traction following FDA clearance of its CT:VQ™ imaging technology, alongside a $150 million institutional placement that bolsters its cash reserves for global expansion.

Novatti Group Limited has reported a striking turnaround to a $3.8 million profit in the first half of 2026, despite a 42% drop in revenue. The fintech’s strategic divestments and reclassification of its AUDC investment signal a pivotal shift in its growth trajectory.

Mesoblast Limited reported its first commercial sales of FDA-approved Ryoncil, generating $48.7 million in net product sales for the half-year ended December 31, 2025, while reducing its net loss by 16%. The company also secured a $125 million five-year credit facility, restructuring its debt to support ongoing commercialization and development.

AF Legal Group Limited has reported a robust half-year performance, with revenue climbing 40% to $17.8 million and profits reaching new heights, driven by strategic acquisitions and operational efficiencies.